Key Takeaways
- Automotive segment powered a strong quarter: SJS automotive sales grew 30.3% Y-o-Y, more than doubling the combined 2W+PV industry production growth of 12.1%, driven by two-wheeler market share gains.
- Margins expanded sharply on operating leverage and softer inputs: Consolidated EBITDA margin rose 134 bps Y-o-Y to 28%, while PAT margin expanded 175 bps Y-o-Y to 17.1%, aided by higher sales and raw material softening.
- Export softness was offset by domestic strength: Domestic sales grew 22.9% Y-o-Y, compensating for geopolitical and macroeconomic headwinds in Europe and North America that pressured export demand.
- Futuristic products are the next growth engine, but still early: In-Mold Electronics, illuminated logos, and cover glass technology could double kit value per car and reach 30%-40% of sales in coming years, though revenue contribution today remains flattish and small.
- What to watch next quarter: Whether export markets begin recovering toward end of Q3 as management cautiously hopes, and any concrete volume visibility on cover glass and optical plastics that would trigger capex plans.
Automotive Outperformance
- Two-wheeler share gains drove the beat: SJS two-wheeler sales grew 31.3% Y-o-Y against industry production growth of just 7.7%, as new business wins and increased share of wallet with key customers like TVS, Bajaj Auto, and Royal Enfield kicked in.
- Passenger vehicle growth was healthy within SJS's customer set: PV sales grew 28.9% Y-o-Y, below the 38.1% industry volume growth, but the PV journey remains in early stages and the trajectory looks promising with new-generation technologies under development.
- H1 outperformance was even wider: Automotive segment grew 38.9% Y-o-Y in H1 versus combined industry production growth of 22.5%, on the back of a strong two-wheeler recovery.
- New customer wins broaden the base: Skoda Auto Volkswagen India added for chrome plating in PVs, Atomberg Technologies for IML parts in consumer appliances, and John Distilleries for speciality decals, marking entry into the FMCG premium segment.
- EV customer count now at 12: BuymyEV and TI India were added in Q2, expanding SJS's electric vehicle supply base among leading domestic manufacturers.
Export Markets: Near-Term Pain, Long-Term Conviction
- Europe and North America dragged exports down: Geopolitical challenges and macroeconomic headwinds in these key markets pressured export revenue, though excluding these regions, export revenue still grew 5.7% Y-o-Y.
- Recovery timeline is cautious and conditional: Management expects near-term softness to persist, with a possible recovery toward the end of Q3 or early Q4, contingent on market settling.
- Russia remains impacted: The Russia market continues to be disrupted, though other geographies may see an upward trend per customer outlook, requiring a wait-and-watch approach.
- Long-term thesis is unchanged: SJS is on the enlisted panel as a global strategic supplier to customers; the market size is very large, and the demand expectation for growth remains intact despite near-term challenges.
- Three-year export target held at 25% of sales: Management reaffirmed the goal of reaching 25% export as a percentage of overall sales, with North America alone estimated by CRISIL at a $2.7 bn market.
- Cost advantage is structural: SJS quotes 5% to 7% cheaper than existing buying prices global customers already have, a moat built on fine-tuned production art and minimal-cost manufacturing.
Thapar: "These are near-term challenges that we see. The long-term outlook for exports remains extremely bullish for the simple reason that the market size, as I said, is very large. And we are also on the enlisted panel as a global strategic supplier to these customers."
Margins: Expansion with Headroom
- Raw material softening was a tailwind: Q2 EBITDA margin improved 134 bps Y-o-Y to 28%, primarily on higher sales, operational efficiency focus, and aided by softening raw material prices.
- Sequential momentum was strong: EBITDA margin improved 161 bps QoQ and PAT margin expanded 135 bps QoQ on the back of higher sales and operational efficiencies.
- Exotech integration is adding to the margin story: All efforts post-acquisition are adding growth and momentum; the quarter benefited from softening raw material prices, though inward efficiency actions and rejection reduction also helped.
- Consolidated EBITDA guidance held at 25%-27%: Management maintained the steady-state range, with the CFO noting the DNA is to deliver more than promised, and acknowledging the quarter's 27.7% H1 performance leaves room to outperform.
- Standalone capacity offers operating leverage without heavy capex: Current utilization is ~60%, leaving 40% headroom; debottlenecking can further increase revenue without significant capital outlay, and standalone can double FY22 revenues on existing capacity.
Thapar: "I'm happy to deliver more than I promised. So that is what our DNA is. So on a steady-state basis, that's what my guidance remains unchanged. So I'm still at 25% to 27%. I know we've done 27.7%. I'd be happier if I do 30% on a consolidated basis."
Futuristic Products: The Next Growth Cycle
- New-age products are still small but strategically vital: Revenue from new-generation products was flattish YoY because volumes are currently low, but these technologies could double the kit value per car as standard fitment spreads from mid and top segments to entry-level vehicles.
- Cover glass and optical plastics are the nearest big opportunity: Still under development with customers and not yet supplying, but customer interest is high; once localization happens, these could reach 30%-40% of sales in coming years.
- Illuminated logos and In-Mold Electronics are gaining traction: Launched and seeing significant engagement and dialogue with customers; prototypes are being built, and management calls these game changers that could propel growth very aggressively for the domestic market.
- All cars will eventually have display screens with cover glasses: The next step is touch panels; SJS is working closely with OEMs, and when localization happens, these will form the bulk of new-age technology products.
- Capex plans await volume visibility: Management expects a much clearer vision on volumes for cover glass and optical plastics in the coming quarter or so, after which capex plans will be built; funding will come largely from internal accruals given INR 130 cr cash on books and strong free cash generation.
Thapar: "So we are very, very excited about this technology. We are thankful to our customers that are working closely with us. And going forward, this could be a complete game changer as to what are the SJS portfolio of products to the customers."
Exotech: Capacity-Stretched but Growing
- Growth has been robust, straining existing capacity: Exotech grew 50% last year and is guiding for 25% this year and 25% the year after; the plant was not built for such growth, and management describes the situation as "touch and go."
- Debottlenecking is buying time: Actions taken over the last year have reduced cycle time and increased output, allowing the asset to be sweated to meet demand while the new plant is built.
- New plant timeline is end-FY24: A land parcel has been identified and an application filed with MIDC for change of name to SJS; building will commence, with the new plant expected on stream toward Q3 or Q4 of FY24.
- Steady-state margin guidance is 15%: Exotech margins benefited this quarter from raw material softening, but the ballpark steady-state expectation remains around 15%.
Thapar: "It is, to be honest, it is touch and go. So that plant was not built for such robust growth. So 50% we grew last year. This year, I'll grow 25% and the outlook for the year after that again is 25%. So it will take some doing. But then we are sweating the asset for all its worth to try and achieve the target."
Inorganic Strategy: Opportunistic and Accretive
- Valuation opportunities are emerging in America and Europe: Many opportunities are cropping up at attractive valuations, but management is cautious and will evaluate proposals against business plan and strategy through a management committee.
- Any acquisition would add to the 25% organic growth already guided: Inorganic expansion is explicitly incremental to the existing revenue growth guidance.
- Post-acquisition playbook is margin-expansive: India manufacturing capability would supplement the acquired entity, product engineering and development could be done in India, while sales teams and market-facing interactions remain with the acquired company's team, creating opportunity for margin expansion given India's good infrastructure.
- North America outreach is already underway: Post-COVID, SJS started doing tech shows in North America, which have opened doors to multiple new plants within the region.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Around 25% Y-o-Y | FY23 |
| PAT growth | Close to 30% Y-o-Y and moving beyond | FY23 and coming years |
| Consolidated EBITDA margin | 25%-27% steady-state | Ongoing |
| Export recovery | Possible recovery toward end of Q3 or early Q4, conditional on market settling | End-Q3 / early Q4 FY23 |
| Export share of sales | Reach 25% of overall sales | Three-year goal (by ~FY25) |
| Exotech growth | 25% Y-o-Y | FY23 and FY24 |
| Exotech new plant | On stream | Q3/Q4 FY24 |
| Exotech steady-state margin | ~15% ballpark | Steady-state |
| Standalone capacity | Double FY22 revenues on current capacity; additional 60,000-70,000 sq ft ready | 5-6 months for new space |
| Cover glass / optical plastics capex | Capex plans to be built once volume visibility firms up | Coming quarter or so for visibility |
| Medium-term guidance (FY23-FY25) | Maintained | FY23 to FY25 |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Consolidated revenue | ₹116.94 cr, +17.3% YoY |
| Sequential revenue growth | +13.3% QoQ |
| EBITDA | ₹33.38 cr, +24.5% YoY |
| EBITDA margin | 28.0%, +134 bps YoY and +161 bps QoQ |
| PAT | ₹19.95 cr, +30.7% YoY |
| PAT margin | 17.1%, +175 bps YoY and +135 bps QoQ |
| H1 FY23 revenue growth | +26.5% YoY |
| H1 FY23 PAT growth | +46% YoY to ₹36.16 cr |
| FY23 revenue growth guidance | ~25% YoY, maintained |
| FY23 PAT growth guidance | close to 30% YoY |
| Consolidated EBITDA margin guidance | 25% to 27%, maintained; H1 averaged 27.7% |
| Automotive segment growth (2W+PV) | +30.3% YoY, vs industry production growth of +12.1% |
| Two-wheeler sales growth | +31.3% YoY, vs industry volume growth of +7.7% |
| Passenger vehicle sales growth | +28.9% YoY, vs industry volume growth of +38.1% |
| Domestic sales growth | +22.9% YoY and +12.5% QoQ |
| Export revenue growth (excl. Europe & North America) | +5.7% YoY |
| Cash and cash equivalents | ~₹129.51 cr as on 30 Sep 2022; net debt-free |
| H1 FY23 free cash flow | ₹32.26 cr added; FCF to EBITDA at 52.7% |
| ROCE | 34.8% as on 30 Sep 2022 |
| ROE | 16.7% as on 30 Sep 2022 |
| Standalone Bangalore plant capacity utilization | ~60%; can double FY22 revenues with current capacity |
| Exotech steady-state margin guidance | 15% ballpark; Q2 benefited from softer raw material prices |
| Exotech growth trajectory | +50% in FY22, guided +25% in FY23, outlook +25% for FY24 |
| New Exotech plant timeline | Expected towards end of FY24 (Q3 or Q4); 12–18 months to commission |
| FY23 capex plan | ~₹55–60 cr total (~₹15 cr regular + ~₹40 cr chrome-plating expansion); ~₹50 cr in H2 |
| New-age products share of sales (FY22) | 16%; could reach 30–40% in coming years |
| EV manufacturers supplied | 12 leading EV OEMs in India |
| Quality awards won in Q2 | 8 awards |